Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza
Sponsor: Azidus Brasil
Summary
2\. Participants will: * Take nitazoxanide 600mg (or placebo) orally twice daily for 7 days, for a total of 14 doses. * Visit the clinic on the 7th day of treatment for a check-up and safety tests. * Keep a diary of their symptoms and other medications used
Official title: Phase 3, Multicenter, Parallel, Randomized, Single-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Nitazoxanide 600 Mg Administered Twice Daily, in the Outpatient Treatment of COVID-19 and Influenza
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
340
Start Date
2025-02
Completion Date
2027-06
Last Updated
2025-02-10
Healthy Volunteers
No
Interventions
Nitazoxanide 600Mg Oral Tablet / placebo oral tablet
1 tablet every 12 hours